Figure 2.
Mean change from baseline FEV1 after different doses of nebulized glycopyrrolate. The first assessment at 5 min post-dose is displayed at 0 h. 
, placebo; 
, 12.5 μg; 
, 50 μg; 
, 100 μg; 
, 200 μg; 
, 400 μg
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.